Last update 01 Nov 2024

Jace Pharma Pty Ltd.

Private Company|
Australia

Overview

Tags

Congenital Disorders
Nervous System Diseases
Other Diseases
Growth factors
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Endocrinology and Metabolic Disease2
Nervous System Diseases2
Top 5 Drug TypeCount
Small molecule drug1
Growth factors1
Top 5 TargetCount
p75NTR(Low affinity neurotrophin receptor p75NTR)1

Related

2
Drugs associated with Jace Pharma Pty Ltd.
Trientine tetrahydrochloride
Target-
Mechanism
Chelating agents
Active Org.
Orphalan SAOrphalan SA [+2]
Originator Org.
Orphalan SAOrphalan SA
Active Indication
Hepatolenticular Degeneration
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
EU [+3]
First Approval Date05 Sep 2017
Cenegermin-BKBJ
Target
p75NTR
Mechanism
p75NTR agonists [+1]
Active Org.
Dompe Farmaceutici SpA [+3]
Originator Org.
Dompe Farmaceutici SpA
Active Indication
Neurotrophic keratitis [+2]
Inactive Indication
Cataract [+6]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
EU [+3]
First Approval Date06 Jul 2017
100 Clinical Results associated with Jace Pharma Pty Ltd.
Login to view more data
0 Patents (Medical) associated with Jace Pharma Pty Ltd.
Login to view more data
100 Deals associated with Jace Pharma Pty Ltd.
Login to view more data
100 Translational Medicine associated with Jace Pharma Pty Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Trientine tetrahydrochloride
Hepatolenticular Degeneration
More
Approved
Cenegermin-BKBJ
 ( p75NTR )		Neurotrophic keratitis
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free